DNA & Genetics Recursion Slides on Data Update as New CEO NamedBy adminNovember 9, 20250 Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug…